Document is current
Any future updates will be listed below
-
Authors
Catalán, José M.
Trigili, Emilio
Nann, Marius
Blanco-Ivorra, Andrea
Lauretti, Clemente
Cordella, Francesca
Ivorra, Eugenio
Armstrong, Elaine
Crea, Simona
Alcañiz, Mariano
Zollo, Loredana
Soekadar, Surjo R.
Vitiello, Nicola
García-Aracil, Nicolás
-
Funding
Funding for this research was provided by:
European Commission (Margarita Salas, G.A. no: 645322)
Ministerio de Ciencia e Innovación (IDI-20190764)
- License Information
-
More Information
Article History
Received: 1 October 2022
Accepted: 26 April 2023
First Online: 6 May 2023
Declarations
:
: The study protocol complied with the Research Ethics Framework of the Economic and Social Research Council (ESRC 2010). In addition, the Office Research Ethics Northern Ireland (ORECNI), which is the regional affiliate of the United Kingdom National Research Ethics Service, conducted a review that ensured establishing ethical methods free from bias and undue influence. Moreover, informed consent was obtained from all subjects involved in the study.
: S.C. and N.V. have interests in a spin-off company (IUVO S.r.l.) developing and commercializing exoskeleton technolo degy that may benefit in the future from the research presented in this article. The IP protecting the NESM technology has currently been licensed to IUVO S.r.l. N.G.A. is founder of Innovative Devices for Rehabilitation and Assistance (iDRhA) while J.M.C. is CEO of iDRhA. The IP protecting the hand exoskeleton used in this study is licensed to iDRhA, which markets this device under the name Helium.
